Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Queensland Health
Farmers Insurance
Chinese Patent Office

Generated: December 16, 2017

DrugPatentWatch Database Preview

Insulin susp isophane semisynthetic purified human - Generic Drug Details

« Back to Dashboard

What are the generic sources for insulin susp isophane semisynthetic purified human and what is the scope of insulin susp isophane semisynthetic purified human freedom to operate?

Insulin susp isophane semisynthetic purified human
is the generic ingredient in two branded drugs marketed by Novo Nordisk Inc and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-eight drug master file entries for insulin susp isophane semisynthetic purified human.

Summary for insulin susp isophane semisynthetic purified human

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novo Nordisk IncNOVOLIN Ninsulin susp isophane semisynthetic purified humanINJECTABLE;INJECTION019065-001Jan 23, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Novo Nordisk IncINSULATARD NPH HUMANinsulin susp isophane semisynthetic purified humanINJECTABLE;INJECTION019449-001May 30, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Federal Trade Commission
Fish and Richardson
US Army
Cantor Fitzgerald
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: